ABCL - AbCellera Biologics GAAP EPS of -$0.02 misses by $0.03 revenue of $45.6M misses by $15.62M
- AbCellera Biologics press release ( NASDAQ: ABCL ): Q2 GAAP EPS of -$0.02 misses by $0.03 .
- Revenue of $45.6M (+65.2% Y/Y) misses by $15.62M .
- $1,022M of cash, cash equivalents, and marketable securities.
For further details see:
AbCellera Biologics GAAP EPS of -$0.02 misses by $0.03, revenue of $45.6M misses by $15.62M